Literature DB >> 32500444

CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis.

W Ma1, P Zhao1, L Zang1, K Zhang1, H Liao1, Z Hu2.   

Abstract

BACKGROUND: Follicular cells give rise to thyroid cancer. Worldwide thyroid cancer incidence continues to rise in recent decades but the mortality rate remains at a stable level. The discovery of novel molecular mechanisms in the pathogenesis of thyroid cancer will promote new diagnostic or therapeutic strategies. Circular RNA (circRNA) is a type of noncoding RNA which is characterized by the covalently closed loop and non-protein coding capacity. The abnormal expression of circRNAs is an important part during the pathogenesis and development of thyroid cancer. CircTP53 is a novel circRNA, and we aimed to investigate its function in the pathogenesis of thyroid cancer and to further demonstrate the underlying molecular mechanism.
METHODS: The levels of circTP53, miR-1233-3p, and other relative mRNA were analyzed by qRT-PCR. Protein levels were shown by Western blot. RNA-pulldown assay and luciferase assay were employed to examine the interaction between circTP53 and miR-1233-3p. Cell proliferation was analyzed by the MTT assay.
RESULTS: CircTP53 was a circRNA highly expressed in thyroid cancer tissues. CircTP53 promoted cell proliferation and cell viability of TPC-1 cells. Knockdown of circTP53 inhibited the expression of Mouse double minute 2 (MDM2) and increased the protein level of p53. CircTP53 acted as a target of miR-1233-3p to increase MDM2 expression. p53 expression in thyroid cancer tissue exhibited a negative correlation with circTP53 expression.
CONCLUSION: In thyroid cancer, overexpressed circTP53 decreased the protein level of p53 via targeting miR-1233-3p/MDM2 axis and promoted cancer cell proliferation.

Entities:  

Keywords:  CircTP53; MDM2; Thyroid cancer; miR-1233-3p; p53

Year:  2020        PMID: 32500444     DOI: 10.1007/s40618-020-01317-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

Review 1.  Thyroid cancer in adolescents and young adults.

Authors:  Daniela Victoria Pirela Araque; Archie Bleyer; Juan P Brito
Journal:  Future Oncol       Date:  2017-06-15       Impact factor: 3.404

2.  Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway.

Authors:  Fukun Chen; Zhiping Feng; Jialun Zhu; Pengjie Liu; Chuanzhou Yang; Rongkai Huang; Zhiyong Deng
Journal:  Cancer Biol Ther       Date:  2018-09-12       Impact factor: 4.742

Review 3.  Thyroid cancer.

Authors:  Maria E Cabanillas; David G McFadden; Cosimo Durante
Journal:  Lancet       Date:  2016-05-27       Impact factor: 79.321

4.  Profiles and Bioinformatics Analysis of Differentially Expressed Circrnas in Taxol-Resistant Non-Small Cell Lung Cancer Cells.

Authors:  Ning Xu; Shaomu Chen; Yufeng Liu; Wei Li; Zeyi Liu; Xiaojie Bian; Chunhua Ling; Min Jiang
Journal:  Cell Physiol Biochem       Date:  2018-08-10

5.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

6.  Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis.

Authors:  Yongsheng Li; Jiahang Hu; Lijuan Li; Shengyan Cai; Hengchun Zhang; Xianfeng Zhu; Guijie Guan; Xiangmei Dong
Journal:  Biochem Biophys Res Commun       Date:  2018-08-06       Impact factor: 3.575

Review 7.  Thyroid cancer.

Authors:  Tobias Carling; Robert Udelsman
Journal:  Annu Rev Med       Date:  2013-11-20       Impact factor: 13.739

Review 8.  The thyroid cancer epidemic, 2017 perspective.

Authors:  Benjamin R Roman; Luc G Morris; Louise Davies
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-10       Impact factor: 3.626

9.  CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.

Authors:  Wen Bi; Jiayu Huang; Chunlei Nie; Bo Liu; Guoqing He; Jihua Han; Rui Pang; Zhaoming Ding; Jin Xu; Jiewu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2018-11-13

10.  LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress.

Authors:  Xiaowen Liu; Zhen-Dong Xiao; Leng Han; Jiexin Zhang; Szu-Wei Lee; Wenqi Wang; Hyemin Lee; Li Zhuang; Junjie Chen; Hui-Kuan Lin; Jing Wang; Han Liang; Boyi Gan
Journal:  Nat Cell Biol       Date:  2016-03-21       Impact factor: 28.824

View more
  6 in total

Review 1.  The emerging function and clinical significance of circRNAs in Thyroid Cancer and Autoimmune Thyroid Diseases.

Authors:  Yu Zhang; Dong-Dong Jia; Yi-Fei Zhang; Meng-Die Cheng; Wen-Xiu Zhu; Pei-Feng Li; Yin-Feng Zhang
Journal:  Int J Biol Sci       Date:  2021-04-17       Impact factor: 6.580

2.  circSSU72 Promotes Cell Proliferation, Migration and Invasion of Papillary Thyroid Carcinoma Cells by Targeting miR-451a/S1PR2 Axis.

Authors:  Zeyu Zhang; Fada Xia; Lei Yao; Bo Jiang; Xinying Li
Journal:  Front Cell Dev Biol       Date:  2022-03-14

3.  CircMCTP2 (has-circ-0000658) facilitates the proliferation and metastasis of bladder carcinoma through modulating the miR-498/murine double minute-2 axis.

Authors:  Qiao Gu; Wenjie Hou; Lijuan Shi; Zonghao Zhu; Huan Liu; Xiaozhou He
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 4.  Function and Clinical Significance of Circular RNAs in Thyroid Cancer.

Authors:  Xuelin Yao; Qiu Zhang
Journal:  Front Mol Biosci       Date:  2022-07-22

Review 5.  A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer.

Authors:  Eman A Toraih; Mohammad H Hussein; Manal S Fawzy; Emad Kandil
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

6.  Circular RNA Circ_0067934 Attenuates Ferroptosis of Thyroid Cancer Cells by miR-545-3p/SLC7A11 Signaling.

Authors:  Hui-Hui Wang; Jia-Ni Ma; Xiao-Rong Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.